Persistent genital arousal disorder (PGAD) is a rare yet distressing condition whereby individuals experience persistent genital sensations (such as orgasms, unwanted stimulation, or tingling and burning sensations) without sexual desire. Whilst the aetiology of the condition is still evolving, there is strong evidence to suggest that psychological factors can play a central role in triggering PGAD, including anxiety, depression and emotional distress. The good news is that there are several psychological methods that can help successfully treat the condition. 

What is persistent genital arousal disorder? 

PGAD, which is also referred to as persistent sexual arousal syndrome (PSAS) or restless genital syndrome (ReGS), involves frequent and prolonged genital arousal outside of sexual desire or stimulation.² It can involve unwanted and intrusive genital sensations, including tingling, throbbing, and pressure. Often, episodes occur at times which can be considered spontaneous and unwanted.¹ The symptoms often lead to an orgasm.² 

A key characteristic of PGAD is that the sensations do not subside with orgasm.² In many cases, the discomfort continues or even worsens afterwards, which can often create a frustrating cycle. Some individuals experience episodes 2-3 times per day, while others may experience periodic flare-ups lasting hours or even days.¹ The unpredictability of PGAD can make it particularly distressing. 

The episodes may not be triggered by one specific thing. Symptoms and triggers can vary from person to person. Common sensations reported by individuals with PGAD include: 

• A persistent feeling of genital tingling, throbbing, or burning
• Uncontrollable arousal that often does not correlate with desire or sexual thoughts
• Spontaneous orgasms that do not provide relief from symptoms 
• Hypersensitivity in the genital area 

Common sensations reported by individuals with PGAD include minor sensations, such as vibrations. Urination or stress can bring on an episode.¹ Often, they may occur spontaneously or in unwanted situations. Patients have reported that associated symptoms include anxiety, restlessness, muscle pain, and disordered sleep.^1,2 

PGAD can affect both genders; however, existing research suggests it is more commonly associated with cisgender women. The exact prevalence is unknown; however, it is expected that as awareness of PGAD increases, there may be more people with PGAD than previously thought.⁴

Patients report that the symptoms and episodes significantly impact their daily lives.¹ The intrusive and undesired nature of the episodes can be distressing. PGAD is associated with a significant emotional and social toll on the individual. Further, fear of the episodes may result in social isolation due to distress, shame, and stigma.² 

The aetiology of PGAD is evolving, and there is still much we do not know about the condition, which can be increasingly frustrating for affected individuals. In some cases, PGAD has been linked to neurological, vascular, or pelvic nerve issues.¹ However, case reports and research suggest that psychological factors may be inextricably linked to PGAD.³

How psychological factors impact PGAD

A growing body of research suggests that the psychological impact of PGAD is profound, with conditions such as anxiety, depression, and emotional distress not only exacerbating symptoms but potentially playing a key role in their onset.^1–5 Research highlights the intricate relationship between PGAD and psychological factors, suggesting that for some individuals, heightened stress response, unresolved emotional trauma, or generalised anxiety disorder (GAD) may contribute to the development, persistence, and frequency of symptoms.¹ The complex interplay of physiological and psychological elements makes PGAD particularly challenging to treat. The complex interplay of factors suggests the need for a multidisciplinary care approach to incorporate pharmacological, biomedical, and psychological interventions.^3,5

A PGAD case report study 

One case study by Ender Cesur (2024) documented a patient who developed PGAD secondary to generalised anxiety disorder. Initially experiencing anxiety-related symptoms such as restlessness, muscle pain, and sleep disturbances, the patient found that masturbating multiple times a day would temporarily alleviate the symptoms. However, over time, spontaneous orgasms occurred without physical contact, and symptoms persisted after the orgasm. Subsequently, the individual underwent extensive medical evaluations, including gynaecological and neurological assessments, but no underlying physiological cause was identified for the symptoms presented. This eventually led to a psychiatric referral. The lack of awareness around PGAD and the complex and varied symptoms can make seeking a diagnosis and care plan complex and stressful for individuals. 

After a psychiatric referral, the patient was hesitant to engage in psychotherapy because of personal shame and stigma associated with the symptoms. They were then prescribed fluoxetine (an SSRI commonly used for anxiety and depression), which did not provide much relief. The dose was then increased, and prescribed alongside clonazepam resulted in a significant improvement of symptoms. The case underscored how psychological distress can both trigger and sustain PGAD symptoms, and demonstrates the importance of addressing underlying or associated mental health concerns to encompass effective treatment plans. 

Many individuals with PGAD report significant shame, embarrassment, and fear, which can delay seeking appropriate medical attention.^1,4 The intrusive nature of symptoms can result in social withdrawal, relationship difficulties, and a decline in overall quality of life. As PGAD remains largely understudied and often misunderstood in the medical community, affected individuals may also encounter scepticism or misdiagnosis. This can further compound psychological distress. Studies indicate that a significant proportion of individuals diagnosed with PGAD have a history of heightened stress, depression, or anxiety, reinforcing the need for psychological assessment and intervention as part of a comprehensive treatment strategy.^1,2,3 

Psychological treatment

Cognitive-behavioural therapy (CBT), mindfulness techniques, and psychoeducation have shown promise in reducing distress, improving emotional regulation and easing the symptoms of episodes. Furthermore, it can be pivotal in managing the condition's unpredictability.⁵ Additionally, relaxation strategies such as guided meditation, exercise, and distraction techniques may offer further relief.^1,2,3

Pharmacological treatments, including SSRIs and benzodiazepines, have been shown to provide relief. It is suggested that they should ideally be combined with psychological therapies to provide a holistic and encompassing approach.^1,5 Given the evolving nature of PGAD, continued research should refine treatment options and advance both the physiological and psychological dimensions of the condition to ensure treatment is effective.^1–5

FAQs

Is persistent genital arousal disorder the same as hypersexuality? 

No, persistent genital arousal disorder is not the same as hypersexuality, and the terms should not be used interchangeably. 

What is the difference between PGAD and hypersexuality? 

PGAD is characterised by the persistent and unwanted genital arousal that occurs without sexual desire. Hypersexuality involves excessive sexual thoughts, urges, or behaviour, which is attached to a compulsive urge for sexual activity. Unlike hypersexuality, PGAD is linked to neurological and psychological factors and not heightened libido. 

How common is PGAD?

It is thought that PGAD is rare and only affects around 1% of the population. However, it is likely that there is significant underreporting due to both stigma and patients' feeling uncomfortable seeking care, and the under-researched nature of the condition. Therefore, these estimates may not be accurate. 

Summary

While PGAD remains a complex and often misunderstood condition, the role of psychological factors in its onset and persistence cannot and should not be ignored. Anxiety, depression, and emotional distress can contribute significantly to the severity and frequency of the symptoms experienced. Furthermore, the demonstrated benefits of psychological intervention make it an integral component of treatment. A multidisciplinary approach that combines pharmacological, medical, and psychological treatments, tailored to the individual's specific needs, holds the most promise for alleviating symptoms and improving patients' well-being. Further research and awareness are imperative to advance treatment options, streamline diagnosis and ultimately ensure that those affected by PGAD receive the comprehensive care they need and deserve.